1Cell.Ai Named Best Healthtech Startup 2026

Recognised for Innovation in Precision Oncology & Patient Impact

Read the Announcement
Request a Callback
  • Home
  • Solutions
  • Technology
  • Products

      Products

      Early-stage Treatment Selection

      OncoTarget®

      Targeted biomarker testing

      OncoHRD®

      HRD testing for PARP therapy

      OncoIndx 360® Endometrium

      Endometrial cancer profiling

      OncoPredikt® BRS

      Breast cancer recurrence risk asse..

      Advanced Precision Oncology

      OncoIndx® Multi-Modal

      Integrated DNA, RNA & Protein Pro..

      OncoIndx® Prime+

      Advanced comprehensive genomic..

      Monitoring & Response

      OncoMonitor® MRD

      Minimal residual disease monitoring

      OncoAlibrex®

      Treatment response monitoring

      Complementary Solutions

      OncoRisk®

      Hereditary cancer risk assessment

      IHC Biomarkers

      Comprehensive biomarker analys.

      DrG

      An AI-powered clinical workspace

  • Resources

      Resources

      Publication

      Peer-reviewed research and manuscripts

      Whitepapers & Reports

      In-depth technical analyses

      Guide & Explainers

      Educational content for all audiences

      FAQs

      Answers to common questions

      Case Studies

      Real-world clinical impact stories

      Expert Insights

      Articles and webinars from our team

      Newsletters

      Latest developments delivered to you

      Blogs

      Latest developments delivered to you

      We’ve just launched a new product!

      Integrated NGS + IHC with WHO-aligned treatment guidance in 10–12 days. 

      Explore Oncolndx® 360° Endometrium
  • Press & News

      Press & News

      Press Releases

      Official announcements and statements

      In the News

      Media coverage and mentions

      Company Updates

      Latest news and developments

      Events & Conferences

      Events, talks, and participation

      Coming Soon

  • About Us

      About Us

      Our Mission 

      Why we do, what we do

      Our Team 

      Leadership, advisors, and board

      Our Lab 

      Certifications and capabilities

      Careers 

      Join our team

      We’re hiring!

      Media & Recognition 

      Awards and press coverage

  • Home
  • Solutions
  • Technology
  • Products

      Products

      Early-stage Treatment Selection

      OncoTarget®

      Targeted biomarker testing

      OncoHRD®

      HRD testing for PARP therapy

      OncoIndx 360® Endometrium

      Endometrial cancer profiling

      OncoPredikt® BRS

      Breast cancer recurrence risk asse..

      Advanced Precision Oncology

      OncoIndx® Multi-Modal

      Integrated DNA, RNA & Protein Pro..

      OncoIndx® Prime+

      Advanced comprehensive genomic..

      Monitoring & Response

      OncoMonitor® MRD

      Minimal residual disease monitoring

      OncoAlibrex®

      Treatment response monitoring

      Complementary Solutions

      OncoRisk®

      Hereditary cancer risk assessment

      IHC Biomarkers

      Comprehensive biomarker analys.

      DrG

      An AI-powered clinical workspace

  • Resources

      Resources

      Publication

      Peer-reviewed research and manuscripts

      Whitepapers & Reports

      In-depth technical analyses

      Guide & Explainers

      Educational content for all audiences

      FAQs

      Answers to common questions

      Case Studies

      Real-world clinical impact stories

      Expert Insights

      Articles and webinars from our team

      Newsletters

      Latest developments delivered to you

      Blogs

      Latest developments delivered to you

      We’ve just launched a new product!

      Integrated NGS + IHC with WHO-aligned treatment guidance in 10–12 days. 

      Explore Oncolndx® 360° Endometrium
  • Press & News

      Press & News

      Press Releases

      Official announcements and statements

      In the News

      Media coverage and mentions

      Company Updates

      Latest news and developments

      Events & Conferences

      Events, talks, and participation

      Coming Soon

  • About Us

      About Us

      Our Mission 

      Why we do, what we do

      Our Team 

      Leadership, advisors, and board

      Our Lab 

      Certifications and capabilities

      Careers 

      Join our team

      We’re hiring!

      Media & Recognition 

      Awards and press coverage

x

    Request a Callback

    Fill in your details and our team will get in touch with you.


    Knowledge Hub

    Blogs & Insights

    Deep-dive into precision oncology, clinical AI research, and the breakthroughs shaping the future of single-cell diagnostics.

    5 Signs Your Cancer Surveillance Plan Might Not Be Enough

    You finished treatment. The scans looked clear.  But is “clear” really the complete picture?   Finishing cancer treatment is one of the most significant...
    sharad
    July 24, 2026
    Read More
    The New Weapon Against Cancer: Antibody-Drug Conjugates and Why Protein Expression Changes Everything

    The New Weapon Against Cancer:  Antibody-Drug Conjugates and Why Protein Expression Changes Everything 

    Imagine a missile that can identify a specific house in an entire city, fly directly to it, and deliver its payload without damaging...
    Jay Nyahale
    August 27, 2026
    Read More
    AI in Cancer Diagnosis: How Artificial Intelligence is Changing Oncology in India

    AI in Cancer Diagnosis: How Artificial Intelligence is Changing Oncology in India

    India is expected to become a developed country by 2047. But as we move towards that future, our disease patterns are also shifting – from infectious diseases to non-communicable ones.  Diabetes, HTN, and cancer are...
    1Cell
    August 25, 2026
    Read More
    Precision Oncology in India: The Future of Personalized Cancer Treatment

    Precision Oncology in India: The Future of Personalized Cancer Treatment

    ​Imagine going to a tailor who doesn’t take a single measurement before making your outfit- instead handing everyone the exact same size off the rack and hoping...
    Jay Nyahale
    August 25, 2026
    Read More
    What Is a Variant of Uncertain Significance: And Should You Be Worried?

    What Is a Variant of Uncertain Significance: And Should You Be Worried?

    Three words that send patients into a spiral of anxiety. Here’s what they actually mean, and what happens next.  You ordered the genetic test. You waited. The...
    1Cell
    August 6, 2026
    Read More

    What Nobody Tells You About Being Cancer Free?

    The scans are clear. The treatment is done.   So why doesn’t it feel like it’s over?   There is a moment, usually in the car...
    sharad
    August 6, 2026
    Read More
    Load More Articles (+6 more)

    Stay Informed

    Stay updated with the latest in Precision oncology

    Join 12,000+ oncologists, researchers, and clinical leaders reading 1Cell.Ai insights.

      Close
      1Cell.Ai
      Powered by  GDPR Cookie Compliance
      Privacy Overview

      This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.